Postradical Prostatectomy Prostate-Specific Antigen Outcomes after 6 Versus 18 Months of Perioperative Androgen-Deprivation Therapy in Men with Localized, Unfavorable Intermediate-Risk or High-Risk Prostate Cancer: Results of Part 2 of a Randomized Phase 2 Trial.
CANCER（2024）
关键词
androgen-deprivation therapy,biochemical recurrence,high-risk,neoadjuvant hormone therapy,pathologic response,prostate cancer,radical prostatectomy
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要